1. Home
  2. TAL vs TWST Comparison

TAL vs TWST Comparison

Compare TAL & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TAL

TAL Education Group

HOLD

Current Price

$11.87

Market Cap

5.4B

Sector

Real Estate

ML Signal

HOLD

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

N/A

Current Price

$125.21

Market Cap

5.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TAL
TWST
Founded
2003
2013
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.2B
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
TAL
TWST
Price
$11.87
$125.21
Analyst Decision
Hold
Buy
Analyst Count
3
8
Target Price
$11.15
$46.88
AVG Volume (30 Days)
4.9M
1.5M
Earning Date
04-23-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
63.89
EPS
N/A
N/A
Revenue
N/A
$376,572,000.00
Revenue This Year
$22.97
$18.91
Revenue Next Year
$17.08
$15.07
P/E Ratio
$23.36
N/A
Revenue Growth
N/A
20.32
52 Week Low
$8.88
$23.30
52 Week High
$13.37
$125.66

Technical Indicators

Market Signals
Indicator
TAL
TWST
Relative Strength Index (RSI) 58.42 70.40
Support Level $10.66 $84.39
Resistance Level $12.61 N/A
Average True Range (ATR) 0.46 8.36
MACD 0.04 3.01
Stochastic Oscillator 65.00 96.18

Price Performance

Historical Comparison
TAL
TWST

About TAL TAL Education Group

TAL Education Group is a leading learning solutions provider in China. It operates a few business lines including enrichment learning, high school academic tutoring, learning technology, and content solutions. Among those business lines, TAL focuses on enrichment learning and content solutions.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Share on Social Networks: